Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1981 1
1985 2
1986 2
1988 1
1995 1
2002 4
2003 1
2004 4
2005 4
2006 4
2007 1
2008 4
2009 3
2010 1
2011 3
2012 1
2013 2
2014 1
2015 3
2016 4
2017 1
2019 5
2020 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators. Kantoff PW, et al. N Engl J Med. 2010 Jul 29;363(5):411-22. doi: 10.1056/NEJMoa1001294. N Engl J Med. 2010. PMID: 20818862 Free article. Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Playing mathematics.
Wertheim M. Wertheim M. Ann N Y Acad Sci. 2019 Dec;1458(1):70-74. doi: 10.1111/nyas.14269. Epub 2019 Oct 28. Ann N Y Acad Sci. 2019. PMID: 31658380
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F; RAISE Study Investigators. Tabernero J, et al. Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Lancet Oncol. 2015. PMID: 25877855 Clinical Trial.
The mystery of our mathematical universe.
Paulson S, Gates SJ Jr, Wertheim M. Paulson S, et al. Among authors: wertheim m. Ann N Y Acad Sci. 2019 Dec;1458(1):9-25. doi: 10.1111/nyas.14026. Epub 2019 Mar 22. Ann N Y Acad Sci. 2019. PMID: 30900261
Corneal transplant rejection following influenza vaccination.
Wertheim MS, Keel M, Cook SD, Tole DM. Wertheim MS, et al. Br J Ophthalmol. 2006 Jul;90(7):925. doi: 10.1136/bjo.2006.093187. Br J Ophthalmol. 2006. PMID: 16782961 Free PMC article. Review. No abstract available.
Ocular presentation of pediatric Miller-Fisher syndrome.
Wertheim MS, Benzimra JD, Jadresic LP, Ferris JD. Wertheim MS, et al. J Pediatr Ophthalmol Strabismus. 2008 Jul-Aug;45(4):245-6. doi: 10.3928/01913913-20080701-16. J Pediatr Ophthalmol Strabismus. 2008. PMID: 18705624
53 results